Role of Roflumilast Among COPD Patients to Prevent Exacerbations: Oral Roflumilast as a New Treatment Modality for COPD Exacerbations - Couverture souple

Laique, Talha; Latif, Hina; Farooq Butt, Nasir

 
9786209935633: Role of Roflumilast Among COPD Patients to Prevent Exacerbations: Oral Roflumilast as a New Treatment Modality for COPD Exacerbations
Couverture souple
ISBN 10 : 620993563X ISBN 13 : 9786209935633
Editeur : LAP LAMBERT Academic Publishing, 2026

Synopsis

Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory disorder and a major cause of morbidity and mortality worldwide, particularly in low- and middle-income countries such as Pakistan, where underdiagnosis and limited healthcare resources remain significant challenges. Despite standard therapies, frequent exacerbations continue to worsen patient outcomes and increase healthcare burden.Roflumilast, an oral phosphodiesterase-4 (PDE-4) inhibitor, has emerged as a promising new treatment option for severe COPD with recurrent exacerbations. This study evaluates the effectiveness and safety of oral roflumilast as an adjunct to standard therapy in preventing exacerbations and improving pulmonary function among COPD patients.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Éditeur
LAP LAMBERT Academic Publishing
Date d'édition
2026
Langue
anglais
ISBN 10 
620993563X
ISBN 13 
9786209935633
Reliure
Broché
Nombre de pages
88
Coordonnées du fabricant
non disponible
Personne responsable
KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne